The thrombin receptor PAR4 supports visceral adipose tissue inflammation.

Adipose tissue Glucose intolerance Inflammation Obesity Protease-activated receptor Thrombin

Journal

Naunyn-Schmiedeberg's archives of pharmacology
ISSN: 1432-1912
Titre abrégé: Naunyn Schmiedebergs Arch Pharmacol
Pays: Germany
ID NLM: 0326264

Informations de publication

Date de publication:
23 Apr 2024
Historique:
received: 20 03 2024
accepted: 11 04 2024
medline: 23 4 2024
pubmed: 23 4 2024
entrez: 23 4 2024
Statut: aheadofprint

Résumé

Thrombin inhibition suppresses adiposity, WAT inflammation and metabolic dysfunction in mice. Protease-activated receptor (PAR)1 does not account for thrombin-driven obesity, so we explored the culprit role of PAR4 in this context. Male WT and PAR-4

Identifiants

pubmed: 38652276
doi: 10.1007/s00210-024-03097-5
pii: 10.1007/s00210-024-03097-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : R01-HL131517, R01-HL136389, R01-HL089598, R01HL163277, R01HL160992
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Altintas MM, Azad A, Nayer B, Contreras G, Zaias J, Faul C, Reiser J, Nayer A (2011) Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res 52:480–488
pubmed: 21148461 pmcid: 3035684 doi: 10.1194/jlr.M011338
Aravani D, Kassi E, Chatzigeorgiou A, Vakrou S (2021) Cardiometabolic syndrome: an update on available mouse models. Thromb Haemost 121:703–715
pubmed: 33280078 doi: 10.1055/s-0040-1721388
Badeanlou L, Furlan-Freguia C, Yang G, Ruf W, Samad F (2011) Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation. Nat Med 17:1490–1497
pubmed: 22019885 pmcid: 3210891 doi: 10.1038/nm.2461
Bastías-Pérez M, Serra D, Herrero L (2020) Dietary options for rodents in the study of obesity. Nutrients 12:3234
pubmed: 33105762 pmcid: 7690621 doi: 10.3390/nu12113234
Beijers HJ, Ferreira I, Spronk HM, Bravenboer B, Dekker JM, Nijpels G, ten Cate H, Stehouwer CD (2012) Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation–the Hoorn Study. Thromb Res 129:557–562
pubmed: 21851966 doi: 10.1016/j.thromres.2011.07.033
Blencowe M, Ahn IS, Saleem Z, Luk H, Cely I, Mäkinen VP, Zhao Y, Yang X (2021) Gene networks and pathways for plasma lipid traits via multitissue multiomics systems analysis. J Lipid Res 62:100019
pubmed: 33561811 pmcid: 7873371 doi: 10.1194/jlr.RA120000713
Bošanská L, Michalský D, Lacinová Z, Dostálová I, Bártlová M, Haluzíková D, Matoulek M, Kasalický M, Haluzík M (2010) The influence of obesity and different fat depots on adipose tissue gene expression and protein levels of cell adhesion molecules. Physiol Res 59:79–88
pubmed: 19249917 doi: 10.33549/physiolres.931705
Brake DK, Smith EO, Mersmann H, Smith CW, Robker RL (2006) ICAM-1 expression in adipose tissue: effects of diet-induced obesity in mice. Am J Physiol Cell Physiol 291:C1232-1239
pubmed: 16807303 doi: 10.1152/ajpcell.00008.2006
Casimiro I, Stull ND, Tersey SA, Mirmira RG (2021) Phenotypic sexual dimorphism in response to dietary fat manipulation in C57BL/6J mice. J Diabetes Complications 35:107795
pubmed: 33308894 doi: 10.1016/j.jdiacomp.2020.107795
Chen HJ, Yan XY, Sun A, Zhang L, Zhang J, Yan YE (2022) High-fat-diet-induced extracellular matrix deposition regulates integrin-FAK signals in adipose tissue to promote obesity. Mol Nutr Food Res 66:e2101088
pubmed: 35106921 doi: 10.1002/mnfr.202101088
Chitongo PB, Roberts LN, Yang L, Patel RK, Lyall R, Luxton R, Aylwin SJB, Arya R (2017) Visceral adiposity is an independent determinant of hypercoagulability as measured by thrombin generation in morbid obesity. TH Open 1:e146–e154
pubmed: 31249920 pmcid: 6524850 doi: 10.1055/s-0037-1608942
Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci U S A 96:11023–11027
pubmed: 10500117 pmcid: 34235 doi: 10.1073/pnas.96.20.11023
Dangwal S, Rauch BH, Gensch T, Dai L, Bretschneider E, Vogelaar CF, Schrör K, Rosenkranz AC (2011) High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 31:624–633
pubmed: 21164077 doi: 10.1161/ATVBAHA.110.219105
de Moura EDM, Dos Reis SA, da Conceição LL, Sediyama C, Pereira SS, de Oliveira LL, Gouveia Peluzio MDC, Martinez JA, Milagro FI (2021) Diet-induced obesity in animal models: points to consider and influence on metabolic markers. Diabetol Metab Syndr 13:32
doi: 10.1186/s13098-021-00647-2
Edén D, Panagiotou G, Mokhtari D, Eriksson JW, Åberg M, Siegbahn A (2019) Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner. Ups J Med Sci 124:158–167
pubmed: 31407948 pmcid: 6758637 doi: 10.1080/03009734.2019.1645248
Fang W, Xie S, Deng W (2023) Epicardial adipose tissue: a potential therapeutic target for cardiovascular diseases. J Cardiovasc Transl Res. https://doi.org/10.1007/s12265-023-10442-1
doi: 10.1007/s12265-023-10442-1 pubmed: 37848803
Feldmann K, Grandoch M, Kohlmorgen C, Valentin B, Gerfer S, Nagy N, Hartwig S, Lehr S, Fender AC, Fischer JW (2019) Decreased M1 macrophage polarization in dabigatran-treated Ldlr-deficient mice: implications for atherosclerosis and adipose tissue inflammation. Atherosclerosis 287:81–88
pubmed: 31233979 doi: 10.1016/j.atherosclerosis.2019.06.897
Fender AC, Rauch BH, Geisler T, Schrör K (2017) Protease-activated receptor PAR-4: an inducible switch between thrombosis and vascular inflammation? Thromb Haemost 117:2013–2025
pubmed: 29044290 doi: 10.1160/TH17-03-0219
Fender AC, Wakili R, Dobrev D (2019) Straight to the heart: pleiotropic antiarrhythmic actions of oral anticoagulants. Pharmacol Res 145:104257
pubmed: 31054953 pmcid: 6987959 doi: 10.1016/j.phrs.2019.104257
Fender AC, Kleeschulte S, Stolte S, Leineweber K, Kamler M, Bode J, Li N, Dobrev D (2020) Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart. Basic Res Cardiol 115:10
pubmed: 31912235 pmcid: 7384378 doi: 10.1007/s00395-019-0771-9
French SL, Hamilton JR (2016) Protease-activated receptor 4: from structure to function and back again. Br J Pharmacol 173:2952–2965
pubmed: 26844674 pmcid: 5341247 doi: 10.1111/bph.13455
Gawałko M, Saljic A, Li N, Abu-Taha I, Jespersen T, Linz D, Nattel S, Heijman J, Fender A, Dobrev D (2023) Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance. Cardiovasc Res 119:614–630
pubmed: 35689487 doi: 10.1093/cvr/cvac093
Girerd N, Scridon A, Bessière F, Chauveau S, Geloen A, Boussel L, Morel E, Chevalier P (2013) Periatrial epicardial fat is associated with markers of endothelial dysfunction in patients with atrial fibrillation. PLoS One 8:e77167
pubmed: 24143210 pmcid: 3797107 doi: 10.1371/journal.pone.0077167
Grandoch M, Flögel U, Virtue S, Maier JK, Jelenik T, Kohlmorgen C, Feldmann K, Ostendorf Y, Castañeda TR, Zhou Z, Yamaguchi Y, Nascimento EBM, Sunkari VG, Goy C, Kinzig M, Sörgel F, Bollyky PL, Schrauwen P, Al-Hasani H, Roden M, Keipert S, Vidal-Puig A, Jastroch M, Haendeler J, Fischer JW (2019) 4-Methylumbelliferone improves the thermogenic capacity of brown adipose tissue. Nat Metab 1:546–559
pubmed: 31602424 pmcid: 6786893 doi: 10.1038/s42255-019-0055-6
Gurriarán-Rodríguez U, Al-Massadi O, Crujeiras AB, Mosteiro CS, Amil-Diz M, Beiroa D, Nogueiras R, Seoane LM, Gallego R, Pazos Y, Casanueva FF, Camiña JP (2011) Preproghrelin expression is a key target for insulin action on adipogenesis. J Endocrinol 210:R1-7
pubmed: 21690170 doi: 10.1530/JOE-11-0233
Han CY, Subramanian S, Chan CK, Omer M, Chiba T, Wight TN, Chait A (2007) Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 56:2260–2273
pubmed: 17563062 doi: 10.2337/db07-0218
Kaji N, Nagakubo D, Hashida S, Takahashi S, Kuratani M, Hirai N, Shirai M, Asai F (2013) Shortened blood coagulation times in genetically obese rats and diet-induced obese mice. J Vet Med Sci 75:1245–1248
pubmed: 23628972 doi: 10.1292/jvms.13-0029
Kajimoto K, Takayanagi S, Sasaki S, Akita H, Harashima H (2012) RNA interference-based silencing reveals the regulatory role of fatty acid-binding protein 4 in the production of IL-6 and vascular endothelial growth factor in 3T3-L1 adipocytes. Endocrinology 153:5629–5636
pubmed: 23008513 doi: 10.1210/en.2012-1456
Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka-Kowatari N, Kumagai K, Sakamoto K, Kobayashi M, Yamauchi T, Ueki K, Oishi Y, Nishimura S, Manabe I, Hashimoto H, Ohnishi Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Nagai R, Kadowaki T (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281:26602–26614
pubmed: 16809344 doi: 10.1074/jbc.M601284200
Konwerski M, Gąsecka A, Opolski G, Grabowski M, Mazurek T (2022) Role of epicardial adipose tissue in cardiovascular diseases: a review. Biology (Basel) 11:355
pubmed: 35336728
Kopec AK, Joshi N, Towery KL, Kassel KM, Sullivan BP, Flick MJ, Luyendyk JP (2014) Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice. J Pharmacol Exp Ther 351:288–297
pubmed: 25138021 pmcid: 4201275 doi: 10.1124/jpet.114.218545
Kopec AK, Abrahams SR, Thornton S, Palumbo JS, Mullins ES, Divanovic S, Weiler H, Owens AP 3rd, Mackman N, Goss A, van Ryn J, Luyendyk JP, Flick MJ (2017) Thrombin promotes diet-induced obesity through fibrin-driven inflammation. J Clin Invest 127:3152–3166
pubmed: 28737512 pmcid: 5531415 doi: 10.1172/JCI92744
Mahajan-Thakur S, Sostmann BD, Fender AC, Behrendt D, Felix SB, Schrör K, Rauch BH (2014) Sphingosine-1-phosphate induces thrombin receptor PAR-4 expression to enhance cell migration and COX-2 formation in human monocytes. J Leukoc Biol 96:611–618
pubmed: 24990321 doi: 10.1189/jlb.3AB1013-567R
Maric I, Krieger JP, van der Velden P, Börchers S, Asker M, Vujicic M, Wernstedt Asterholm I, Skibicka KP (2022) Sex and species differences in the development of diet-induced obesity and metabolic disturbances in rodents. Front Nutr 9:828522
pubmed: 35284452 pmcid: 8908889 doi: 10.3389/fnut.2022.828522
Merali S, Wang Z, Frost C, Callejo M, Hedrick M, Hui L, Meadows Shropshire S, Xu K, Bouvier M, DeSouza MM, Yang J (2022) New oral protease-activated receptor 4 antagonist BMS-986120: tolerability, pharmacokinetics, pharmacodynamics, and gene variant effects in humans. Platelets 33:969–978
pubmed: 35758258 doi: 10.1080/09537104.2022.2088719
Merali S, Wang Z, Frost C, Meadows-Shropshire S, Hawthorne D, Yang J, Seiffert D (2023) First-in-human study to assess the safety, pharmacokinetics, and pharmacodynamics of BMS-986141, a novel, reversible, small-molecule, PAR4 agonist in non-Japanese and Japanese healthy participants. Platelets 34:2222846
pubmed: 37394920 doi: 10.1080/09537104.2023.2222846
Mihara M, Aihara K, Ikeda Y, Yoshida S, Kinouchi M, Kurahashi K, Fujinaka Y, Akaike M, Matsumoto T (2010) Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db mice. Endocrinology 151:513–519
pubmed: 19966184 doi: 10.1210/en.2009-0661
Mihara K, Ramachandran R, Saifeddine M, Hansen KK, Renaux B, Polley D, Gibson S, Vanderboor C, Hollenberg MD (2016) Thrombin-mediated direct activation of proteinase-activated receptor-2: another target for thrombin signaling. Mol Pharmacol 89:606–614
pubmed: 26957205 doi: 10.1124/mol.115.102723
Misiou A, Garmey JC, Hensien JM, Harmon DB, Osinski V, McSkimming C, Marshall MA, Fischer JW, Grandoch M, McNamara CA (2021) Helix-loop-helix factor Id3 (inhibitor of differentiation 3): a novel regulator of hyaluronan-mediated adipose tissue inflammation. Arterioscler Thromb Vasc Biol 41:796–807
pubmed: 33380173 doi: 10.1161/ATVBAHA.120.315588
Miszta A, Kopec AK, Pant A, Holle LA, Byrnes JR, Lawrence DA, Hansen KC, Flick MJ, Luyendyk JP, de Laat B, Wolberg AS (2020) A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice. Blood 135:1704–1717
pubmed: 32315384 pmcid: 7205812 doi: 10.1182/blood.2019004267
Molina-Ayala MA, Rodríguez-Amador V, Suárez-Sánchez R, León-Solís L, Gómez-Zamudio J, Mendoza-Zubieta V, Cruz M, Suárez-Sánchez F (2022) Expression of obesity- and type-2 diabetes-associated genes in omental adipose tissue of individuals with obesity. Gene 815:146181
pubmed: 34995730 doi: 10.1016/j.gene.2021.146181
Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin B, Zambon A, Barter P, Fruchart JC, Eckel RH (2019) Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol 7:715–725
pubmed: 31301983 doi: 10.1016/S2213-8587(19)30084-1
Nishimura S, Manabe I, Nagasaki M, Seo K, Yamashita H, Hosoya Y, Ohsugi M, Tobe K, Kadowaki T, Nagai R, Sugiura S (2008) In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest 118:710–721
pubmed: 18202748 pmcid: 2200301
Pape R, Rauch BH, Rosenkranz AC, Kaber G, Schrör K (2008) Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 28:534–540
pubmed: 18162607 doi: 10.1161/ATVBAHA.107.159483
Pavic G, Grandoch M, Dangwal S, Jobi K, Rauch BH, Doller A, Oberhuber A, Akhyari P, Schrör K, Fischer JW, Fender AC (2014) Thrombin receptor protease-activated receptor 4 is a key regulator of exaggerated intimal thickening in diabetes mellitus. Circulation 130:1700–1711
pubmed: 25239438 doi: 10.1161/CIRCULATIONAHA.113.007590
Pettersson US, Waldén TB, Carlsson PO, Jansson L, Phillipson M (2012) Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS One 7:e46057
pubmed: 23049932 pmcid: 3458106 doi: 10.1371/journal.pone.0046057
Prüller F, Raggam RB, Posch V, Almer G, Truschnig-Wilders M, Horejsi R, Möller R, Weghuber D, Ille R, Schnedl W, Mangge H (2012) Trunk weighted obesity, cholesterol levels and low grade inflammation are main determinants for enhanced thrombin generation. Atherosclerosis 220:215–218
pubmed: 22035573 doi: 10.1016/j.atherosclerosis.2011.09.035
Renna SA, McKenzie SE, Michael JV (2023) Species differences in platelet protease-activated receptors. Int J Mol Sci 24:8298
pubmed: 37176005 pmcid: 10179473 doi: 10.3390/ijms24098298
Roberts LD, Virtue S, Vidal-Puig A, Nicholls AW, Griffin JL (2009) Metabolic phenotyping of a model of adipocyte differentiation. Physiol Genomics 39:109–119
pubmed: 19602617 pmcid: 2765066 doi: 10.1152/physiolgenomics.90365.2008
Scott L Jr, Fender AC, Saljic A, Li L, Chen X, Wang X, Linz D, Lang J, Hohl M, Twomey D, Pham TT, Diaz-Lankenau R, Chelu MG, Kamler M, Entman ML, Taffet GE, Sanders P, Dobrev D, Li N (2021) NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias. Cardiovasc Res 117:1746–1759
pubmed: 33523143 doi: 10.1093/cvr/cvab024
Soma MR, Gotto AM Jr, Ghiselli G (1989) Rapid modulation of rat adipocyte lipoprotein lipase: effect of calcium, A23187 ionophore, and thrombin. Biochim Biophys Acta 1003:307–314
pubmed: 2545263 doi: 10.1016/0005-2760(89)90237-3
Stoppa-Vaucher S, Dirlewanger MA, Meier CA, de Moerloose P, Reber G, Roux-Lombard P, Combescure C, Saudan S, Schwitzgebel VM (2012) Inflammatory and prothrombotic states in obese children of European descent. Obesity (Silver Spring) 20:1662–1668
pubmed: 22484367 doi: 10.1038/oby.2012.85
Strande JL, Phillips SA (2009) Thrombin increases inflammatory cytokine and angiogenic growth factor secretion in human adipose cells in vitro. J Inflamm (Lond) 6:4
pubmed: 19267924 doi: 10.1186/1476-9255-6-4
Sun C, Li A, Wang H, Ma J, Hou J (2023) Positive regulation of acetate in adipocyte differentiation and lipid deposition in obese mice. Nutrients 15:3736
pubmed: 37686768 pmcid: 10489952 doi: 10.3390/nu15173736

Auteurs

Sonja Kleeschulte (S)

Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Düsseldorf, Germany.

Vivien Fischinger (V)

Institute for Pharmacology and Clinical Pharmacology, University Hospital Düsseldorf, Düsseldorf, Germany.

Lisa Öhlke (L)

Institute for Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Duisburg, Germany.

Johannes Bode (J)

Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Düsseldorf, Germany.

Markus Kamler (M)

Department of Thoracic and Cardiovascular Surgery, University Hospital Essen, Essen, Germany.

Dobromir Dobrev (D)

Institute for Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Duisburg, Germany.
Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montréal, Canada.
Department of Integrative Physiology, Baylor College of Medicine, Houston, TX, USA.

Maria Grandoch (M)

Institute for Translational Pharmacology and CARID Cardiovascular Research Institute Düsseldorf, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Anke C Fender (AC)

Institute for Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Duisburg, Germany. anke.fender@uk-essen.de.

Classifications MeSH